X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (37) 37
article (29) 29
immunotherapy (28) 28
hematology (22) 22
immunology (22) 22
oncology (22) 22
female (21) 21
transplantation (20) 20
male (16) 16
adult (15) 15
cancer (15) 15
leukemia (15) 15
stem cells (15) 15
middle aged (14) 14
chronic myelogenous leukemia (13) 13
hemic and lymphatic diseases (13) 13
care and treatment (10) 10
leukemia, myeloid, acute - therapy (10) 10
stem-cell transplantation (10) 10
t-lymphocytes, cytotoxic - immunology (10) 10
acute myeloid-leukemia (9) 9
antigen (9) 9
cross-presentation (9) 9
fludarabine (9) 9
hla-a2 antigen - immunology (9) 9
aml (8) 8
breast cancer (8) 8
hematology, oncology and palliative medicine (8) 8
leukemia, myeloid, acute - immunology (8) 8
lymphocytes (8) 8
peptides - immunology (8) 8
pr1 (8) 8
t cells (8) 8
treatment outcome (8) 8
versus-host-disease (8) 8
aged (7) 7
analysis (7) 7
cell line, tumor (7) 7
health aspects (7) 7
immunity (7) 7
acute myeloid leukemia (6) 6
animals (6) 6
antigens (6) 6
antigens, neoplasm - immunology (6) 6
bone-marrow-transplantation (6) 6
breast neoplasms - immunology (6) 6
cytotoxic t-lymphocytes (6) 6
immune response (6) 6
mice (6) 6
myeloblastin - immunology (6) 6
neutrophil elastase (6) 6
prognosis (6) 6
survival analysis (6) 6
transplantation, homologous (6) 6
adaptive immunity (5) 5
allogeneic stem cell transplantation (5) 5
cell biology (5) 5
clinical trials (5) 5
colony-stimulating factor (5) 5
expression (5) 5
hematopoietic stem cell transplantation (5) 5
histocompatibility antigens (5) 5
hla histocompatibility antigens (5) 5
leukemia, myeloid, acute - pathology (5) 5
lymphocytes t (5) 5
medical research (5) 5
myeloid leukemia (5) 5
therapy (5) 5
vaccination (5) 5
young adult (5) 5
abridged index medicus (4) 4
antigen presentation (4) 4
busulfan (4) 4
cancer vaccines - therapeutic use (4) 4
chemotherapy (4) 4
chimerism (4) 4
conditioning regimen (4) 4
dendritic cells (4) 4
development and progression (4) 4
elastase (4) 4
epitopes - immunology (4) 4
epitopes, t-lymphocyte - immunology (4) 4
graft vs host disease - etiology (4) 4
graft vs host disease - prevention & control (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
hematopoietic stem cells (4) 4
histocompatibility antigen hla (4) 4
hla-a2 antigen - metabolism (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukocyte elastase - immunology (4) 4
leukocyte elastase - metabolism (4) 4
mds (4) 4
medicine, research & experimental (4) 4
myelodysplastic syndrome (4) 4
myelodysplastic syndromes - therapy (4) 4
patients (4) 4
peptide fragments - immunology (4) 4
peptides (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CLINICAL CANCER RESEARCH, ISSN 1078-0432, 04/2019, Volume 25, Issue 8, pp. 2610 - 2620
Purpose: Inefficient homing of adoptively transferred cytotoxic T lymphocytes (CTLs) to tumors is a major limitation to the efficacy of adoptive cellular... 
ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII | CELLS | EX-VIVO FUCOSYLATION | GROUP-STUDY I-01 | LEUKOCYTE RECRUITMENT | ONCOLOGY | E75 VACCINE | TUMOR | CATHEPSIN-G | ACUTE MYELOID-LEUKEMIA | CANCER-IMMUNOTHERAPY
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2018, Volume 9, p. 3153
Despite substantial advances in the treatment of acute myeloid leukemia (AML), only 30% of patients survive more than 5 years. Therefore, new therapeutics are... 
re-directed cytotoxicity | bi-specific antibody | acute myeloid leukemia | PR1 | cancer immunotherapy | IMMUNITY | THERAPY | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | CROSS-PRESENTATION | T cells | Research
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2768 - 2768
Abstract Acute myeloid leukemia (AML) stem cells (LSC) are an extremely rare fraction of the overall disease (likely <0.3%), largely quiescent, and capable of... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4651 - 4651
Abstract Purpose: We have previously reported the outcomes of NMA alloSCT in 47 patients with relapsed/chemosensitive follicular lymphoma (FL) who received a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4584 - 4584
Abstract Purpose: Rituximab (R) use can attenuate the risks of graft-versus-host disease (GVHD) after non-myeloablative allogeneic (NMA) alloSCT. There is a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3373 - 3373
Abstract Background: Timed sequential busulfan (TSB) with fludarabine is a promising myeloablative conditioning regimen for patients undergoing matched donor... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4667 - 4667
Abstract Outcome of persons >65 years with acute myeloid leukemia (AML) is poor. Allogeneic transplant can cure some of these patients but is associated with... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 483 - 483
Abstract Background: Encouraging results have been reported in AML/MDS patients (pts) treated with checkpoint inhibitors (CPIs) in frontline and relapsed... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3450 - 3450
Abstract Introduction An HLA-matched unrelated donor (MUD) has been accepted as the next best option for patients who do not have a matched-related donor (MRD)... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2141 - 2141
Abstract Introduction Outcomes after allogeneic stem cell transplant (AHSCT) are influenced by both disease and patient related factors. We hypothesized that... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4542 - 4542
Abstract Many aggressive hematologic malignancies are exquisitely responsive to immunotherapy. While allogeneic (allo) hematopoietic stem cell transplantation... 
Journal Article
Journal of Immunology, ISSN 0022-1767, 09/2018, Volume 201, Issue 5, pp. 1389 - 1399
Proteinase 3 (P3), a serine protease expressed by myeloid cells, localized within azurophil granules, and also expressed on the cellular membrane of... 
WEGENERS-GRANULOMATOSIS | NEUTROPHIL PROTEINASE-3 | PROTEASE-ACTIVATED RECEPTOR-2 | SERINE PROTEASES | PROGNOSTIC-FACTORS | IMMUNE-RESPONSES | CATHEPSIN-G | IMMUNOLOGY | CATALYTIC-ACTIVITY | CANCER | CROSS-PRESENTATION | Immune Regulation
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.